Oncology and Hematology

129-144 of 790

• 

  RestartResume

  Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies

  RestartResume

  Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies

  Project Oncology®

  Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies

  Alexandria May, PharmD, BCPS; Chandrikha Chandrasekharan, MBBS

  • 

    

    Alexandria May, PharmD, BCPS

  • 

    

    Chandrikha Chandrasekharan, MBBS

• 

  RestartResume

  Navigating Classification of High-Grade Neuroendocrine Neoplasms

  RestartResume

  Navigating Classification of High-Grade Neuroendocrine Neoplasms

  Project Oncology®

  Navigating Classification of High-Grade Neuroendocrine Neoplasms

  Charles Turck, PharmD, BCPS, BCCCP; Rohit Thummalapalli, MD

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Rohit Thummalapalli, MD

• 

  RestartResume

  Optimizing Treatment Intensity in Early-Stage TNBC

  RestartResume

  Optimizing Treatment Intensity in Early-Stage TNBC

  Project Oncology®

  Optimizing Treatment Intensity in Early-Stage TNBC

  Roberto Leon-Ferre, MD

  • 

    

    Roberto Leon-Ferre, MD

• 

  RestartResume

  Impact of Infertility & Elective Fertility Among Female Oncologists

  RestartResume

  Impact of Infertility & Elective Fertility Among Female Oncologists

  Project Oncology®

  Impact of Infertility & Elective Fertility Among Female Oncologists

  Emily MacDuffie, MD

  • 

    

    Emily MacDuffie, MD

• 

  RestartResume

  Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm

  RestartResume

  Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm

  Project Oncology®

  Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm

  Jacob Sands, MD; Joseph O. Jacobson, MD

  • 

    

    Jacob Sands, MD

  • 

    

    Joseph O. Jacobson, MD

• 

  RestartResume

  Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment

  RestartResume

  Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment

  Project Oncology®

  Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment

  Roberto Leon-Ferre, MD

  • 

    

    Roberto Leon-Ferre, MD

• 

  RestartResume

  Navigating NUT Carcinoma: Diagnosis and Treatment Strategies

  RestartResume

  Navigating NUT Carcinoma: Diagnosis and Treatment Strategies

  Project Oncology®

  Navigating NUT Carcinoma: Diagnosis and Treatment Strategies

  Jacob Sands, MD; Jia Luo, MD

  • 

    

    Jacob Sands, MD

  • 

    

    Jia Luo, MD

• 

  RestartResume

  Matching TNBC Treatment Intensity to Patient Needs

  RestartResume

  Matching TNBC Treatment Intensity to Patient Needs

  Project Oncology®

  Matching TNBC Treatment Intensity to Patient Needs

  Roberto Leon-Ferre, MD

  • 

    

    Roberto Leon-Ferre, MD

• 

  RestartResume

  Implementing Lifestyle Medicine in Breast Cancer Survivorship Care

  RestartResume

  Implementing Lifestyle Medicine in Breast Cancer Survivorship Care

  Project Oncology®

  Implementing Lifestyle Medicine in Breast Cancer Survivorship Care

  Amy Comander, MD

  • 

    

    Amy Comander, MD

• 

  RestartResume

  Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice

  RestartResume

  Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice

  MinuteCE®

  Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice

  Jennifer Johnson, MD, PhD

  0.50 program credits

  • 

    

    Jennifer Johnson, MD, PhD

  0.50 program credits

• 

  RestartResume

  Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies

  RestartResume

  Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies

  Project Oncology®

  Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies

  Charles Turck, PharmD, BCPS, BCCCP; Matthew Hadfield, MD

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Matthew Hadfield, MD

• 

  RestartResume

  DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance

  RestartResume

  DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance

  Project Oncology®

  DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance

  Daniel Hertz, PhD, PharmD

  • 

    

    Daniel Hertz, PhD, PharmD

• 

  RestartResume

  Redefining Cancer Care with Functional Precision Medicine 

  RestartResume

  Redefining Cancer Care with Functional Precision Medicine 

  Project Oncology®

  Redefining Cancer Care with Functional Precision Medicine 

  Matt Birnholz, MD; Jim Foote, MBA

  • 

    

    Matt Birnholz, MD

  • 

    

    Jim Foote, MBA

• 

  RestartResume

  All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care

  RestartResume

  All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care

  MinuteCE®

  All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care

  Adam J. Luginbuhl, MD; Jennifer Johnson, MD, PhD

  0.50 program credits

  • 

    

    Adam J. Luginbuhl, MD

  • 

    

    Jennifer Johnson, MD, PhD

  0.50 program credits

• 

  RestartResume

  Managing Immunotherapy Toxicities in Lung Cancer Patients 

  RestartResume

  Managing Immunotherapy Toxicities in Lung Cancer Patients 

  Project Oncology®

  Managing Immunotherapy Toxicities in Lung Cancer Patients 

  Jacob Sands, MD; Aliyah Pabani, MD

  • 

    

    Jacob Sands, MD

  • 

    

    Aliyah Pabani, MD

• 

  MinuteCE®

  Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC

  Jennifer Johnson, MD, PhD; Adam J. Luginbuhl, MD

  0.50 credits 5 episodes

  • 

    

    Jennifer Johnson, MD, PhD

  • 

    

    Adam J. Luginbuhl, MD

  0.50 credits 5 episodes

• Previous
• 1
• 2
• …
• 7
• 8
• 9
• 10
• 11
• …
• 49
• 50
• Next